Behnam Mohammadi
Overview
Explore the profile of Behnam Mohammadi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
232
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Linsenmeier L, Mohammadi B, Shafiq M, Frontzek K, Bar J, Shrivastava A, et al.
Sci Adv
. 2021 Nov;
7(48):eabj1826.
PMID: 34818048
The prion protein (PrP) is a central player in neurodegenerative diseases, such as prion diseases or Alzheimer’s disease. In contrast to disease-promoting cell surface PrP, extracellular fragments act neuroprotective by...
12.
Middelkamp M, Ruck L, Krisp C, Sumislawski P, Mohammadi B, Dottermusch M, et al.
Acta Neuropathol Commun
. 2021 Nov;
9(1):185.
PMID: 34801069
LIN28A overexpression has been identified in malignant brain tumors called embryonal tumors with multilayered rosettes (ETMR) but its specific role during brain development remains largely unknown. Radial glia cells of...
13.
Ingwersen T, Linnenberg C, DAcunto E, Temori S, Paolucci I, Wasilewski D, et al.
Sci Rep
. 2021 Apr;
11(1):8766.
PMID: 33888787
Familial encephalopathy with neuroserpin inclusion bodies (FENIB) is a progressive neurodegenerative disease caused by point mutations in the gene for neuroserpin, a serine protease inhibitor of the nervous system. Different...
14.
Mohammadi B, Glatzel M, Altmeppen H
Neural Regen Res
. 2020 Dec;
16(7):1431-1432.
PMID: 33318441
No abstract available.
15.
Brenna S, Altmeppen H, Mohammadi B, Rissiek B, Schlink F, Ludewig P, et al.
J Extracell Vesicles
. 2020 Sep;
9(1):1809065.
PMID: 32944194
Extracellular vesicles (EVs) are important means of intercellular communication and a potent tool for regenerative therapy. In ischaemic stroke, transient blockage of a brain artery leads to a lack of...
16.
Mohammadi B, Linsenmeier L, Shafiq M, Puig B, Galliciotti G, Giudici C, et al.
Mol Neurobiol
. 2020 May;
57(6):2812-2829.
PMID: 32367491
The structurally disordered N-terminal half of the prion protein (PrP) is constitutively released into the extracellular space by an endogenous proteolytic cleavage event. Once liberated, this N1 fragment acts neuroprotective...
17.
Mohammadi B, Maboud H, Seyedi S
J Food Sci Technol
. 2019 Aug;
56(8):3571-3578.
PMID: 31413384
Different species of are rich in various mineral and natural antioxidants' compounds and have numerous pharmacological effects with a gamut running from being anticholinesterasic and antitumor to being antidiabetic, etc....
18.
Linsenmeier L, Mohammadi B, Wetzel S, Puig B, Jackson W, Hartmann A, et al.
Mol Neurodegener
. 2018 Apr;
13(1):18.
PMID: 29625583
Background: Proteolytic processing of the prion protein (PrP<superscript>C</superscript>) by endogenous proteases generates bioactive membrane-bound and soluble fragments which may help to explain the pleiotropic roles of this protein in the...
19.
Linsenmeier L, Altmeppen H, Wetzel S, Mohammadi B, Saftig P, Glatzel M
Biochim Biophys Acta Mol Cell Res
. 2017 Jul;
1864(11 Pt B):2128-2137.
PMID: 28693923
Proteolytic processing of the cellular and disease-associated form of the prion protein leads to generation of bioactive soluble prion protein fragments and modifies the structure and function of its cell-bound...
20.
Meka D, Muller-Rischart A, Nidadavolu P, Mohammadi B, Motori E, Ponna S, et al.
J Clin Invest
. 2015 Mar;
125(5):1873-85.
PMID: 25822020
Parkin and the glial cell line-derived neurotrophic factor (GDNF) receptor RET have both been independently linked to the dopaminergic neuron degeneration that underlies Parkinson's disease (PD). In the present study,...